0123 GMT - Ansell's annual result and outlook leaves UBS analysts with a lot of questions. In fact, they list more than two dozen queries for management on topics including manufacturing, potential divestments and the impact of raw-material costs on pricing of the Australia-listed company's personal-protective equipment. With Ansell targeting the U.S. as one of five high-margin growth markets, the investment bank's analysts wonder whether the company has sufficient manufacturing capacity across all its regions. Are any regions or facilities currently under review? They want to know if Ansell sees a strategic reason to further rationalize manufacturing sites or even countries, and what sort of capital expenditure would be required. UBS has a last-published neutral stock rating and a target of 38.70 Australian dollars. Shares are down 0.8% at A$41.02.